seekingalpha.com
/2 weeks ago
Latest updates for Cofrx
Fresh curated links around COFRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
- Market Update: COF, EFX, UAL, MRNA
- Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/4 days ago
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...
fool.com
/1 week ago
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
This clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.
fool.com
/1 week ago
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.
seekingalpha.com
/4 days ago
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...
fool.com
/2 weeks ago
Bicara (BCAX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateMay 11, 2026, at 8:30 a.m. ETCall participantsChief Executive Officer — Claire Mazumdar ClemonChief Medical Officer — Bill SchelmanChief Commerc...
seekingalpha.com
/1 month ago
Industry group says health plans have cut 11% of prior authorizations
fool.com
/2 weeks ago
Achieve (ACHV) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Andrew Goldberg, M.D.Need a quote from a Motley Fool analyst? Em...
fool.com
/2 weeks ago
Achieve (ACHV) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Andrew Goldberg, M.D.Need a quote from a Motley Fool analyst? Em...
pharmexec.com
/2 days ago
<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Breztri]]>
seekingalpha.com
/4 weeks ago
The Vita Coco Company, Inc. (COCO) Q1 2026 Earnings Call Transcript
pharmexec.com
/2 days ago
<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>
fool.com
/2 weeks ago
Accendra Health (ACH) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEMay 11, 2026, 8:30 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — Edward PesickaChief Financial Officer — Jonathan LeonChief...
fool.com
/2 weeks ago
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026, at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Stephen L. SilvestroChief Financial Officer — Edward StelmakhCh...
fool.com
/1 week ago
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.
seekingalpha.com
/1 week ago
Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript
fool.com
/2 weeks ago
Capricor (CAPR) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Linda MarbánChief Financial Officer — Anthony J. BergmannNeed a...
fool.com
/2 weeks ago
Compass (CMPS) Q1 2026 Earnings Transcript
Image source: The Motley Fool. COMPASS Pathways Q1 2026 Earnings Call TranscriptDateWednesday, May 13, 2026 at 8 a.m. ETCall participantsChief Executive Officer — Kabir NathChief...
pharmexec.com
/1 month ago
<![CDATA[FDA Awards Priority Voucher to Compass for Psychedelic Therapy in Treatment-Resistant Depression]]>
fool.com
/2 weeks ago
Fennec (FENC) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. DateThursday, May 14, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer & Board Member — Jeffrey HackmanChief Financial Officer — Rob...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Cofrx
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source